Stephan Rietbrock

3.0k total citations
38 papers, 2.3k citations indexed

About

Stephan Rietbrock is a scholar working on Pharmacology, Cardiology and Cardiovascular Medicine and Oncology. According to data from OpenAlex, Stephan Rietbrock has authored 38 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 8 papers in Cardiology and Cardiovascular Medicine and 8 papers in Oncology. Recurrent topics in Stephan Rietbrock's work include Atrial Fibrillation Management and Outcomes (6 papers), Pharmacogenetics and Drug Metabolism (6 papers) and Analytical Methods in Pharmaceuticals (4 papers). Stephan Rietbrock is often cited by papers focused on Atrial Fibrillation Management and Outcomes (6 papers), Pharmacogenetics and Drug Metabolism (6 papers) and Analytical Methods in Pharmaceuticals (4 papers). Stephan Rietbrock collaborates with scholars based in Germany, United Kingdom and Netherlands. Stephan Rietbrock's co-authors include Carlos Martínez, Tjeerd van Staa, Uwe Fuhr, Arlene M. Gallagher, Luke Bamber, Anja Katholing, Alexander T. Cohen, M Zaigler, Jonathan Plumb and Emma Heeley and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, BMJ and Journal of Bone and Mineral Research.

In The Last Decade

Stephan Rietbrock

38 papers receiving 2.2k citations

Peers

Stephan Rietbrock
PA Routledge United Kingdom
Diane K. Wysowski United States
Raymond Miller United States
Shashank Rohatagi United States
W.H.W. Inman United Kingdom
Stephan Rietbrock
Citations per year, relative to Stephan Rietbrock Stephan Rietbrock (= 1×) peers Sebastian Harder

Countries citing papers authored by Stephan Rietbrock

Since Specialization
Citations

This map shows the geographic impact of Stephan Rietbrock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephan Rietbrock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephan Rietbrock more than expected).

Fields of papers citing papers by Stephan Rietbrock

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephan Rietbrock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephan Rietbrock. The network helps show where Stephan Rietbrock may publish in the future.

Co-authorship network of co-authors of Stephan Rietbrock

This figure shows the co-authorship network connecting the top 25 collaborators of Stephan Rietbrock. A scholar is included among the top collaborators of Stephan Rietbrock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephan Rietbrock. Stephan Rietbrock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cairns, Victoria, Christopher Wallenhorst, Stephan Rietbrock, & Carlos Martínez. (2019). Incidence of Lyme disease in the UK: a population-based cohort study. BMJ Open. 9(7). e025916–e025916. 34 indexed citations
2.
Katholing, Anja, Stephan Rietbrock, Luke Bamber, Carlos Martínez, & Alexander T. Cohen. (2016). Epidemiology of first and recurrent venous thromboembolism in patients with active cancer. Thrombosis and Haemostasis. 117(1). 57–65. 190 indexed citations
3.
Martínez, Carlos, Samy Suissa, Stephan Rietbrock, et al.. (2016). Testosterone treatment and risk of venous thromboembolism: population based case-control study. BMJ. 355. i5968–i5968. 128 indexed citations
4.
Bamber, Luke, et al.. (2014). Epidemiology of first and recurrent venous thromboembolism: A population-based cohort study in patients without active cancer. Thrombosis and Haemostasis. 112(8). 255–263. 142 indexed citations
6.
Gorkow, C., Stephan Rietbrock, Christian Sieder, et al.. (2009). The effects of a special Agnus castus extract (BP1095E1) on prolactin secretion in healthy male subjects. Experimental and Clinical Endocrinology & Diabetes. 104(6). 447–453. 23 indexed citations
7.
Gallagher, Arlene M., et al.. (2008). Initiation and persistence of warfarin or aspirin in patients with chronic atrial fibrillation in general practice: do the appropriate patients receive stroke prophylaxis?. Journal of Thrombosis and Haemostasis. 6(9). 1500–1506. 179 indexed citations
9.
Rietbrock, Stephan, Melvin Olson, & Tjeerd van Staa. (2008). The potential effects on fracture outcomes of improvements in persistence and compliance with bisphosphonates. QJM. 102(1). 35–42. 26 indexed citations
10.
Martínez, Carlos, Henrik W. Finnern, Stephan Rietbrock, et al.. (2008). Patterns of treatment for restless legs syndrome in primary care in the United Kingdom. Clinical Therapeutics. 30(2). 405–418. 3 indexed citations
11.
Jetter, Alexander, Stephan Rietbrock, Dirk Kasel, et al.. (2007). Population Pharmacokinetics of the BEACOPP Polychemotherapy Regimen in Hodgkin???s Lymphoma and its Effect on Myelotoxicity. Clinical Pharmacokinetics. 46(4). 319–333. 16 indexed citations
12.
Martínez, Carlos, Stephan Rietbrock, Deborah Ashby, et al.. (2005). Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: nested case-control study. BMJ. 330(7488). 389–389. 185 indexed citations
13.
Hinz, Burkhard, Daniel Auge, Thomas Rau, et al.. (2003). Simultaneous determination of aceclofenac and three of its metabolites in human plasma by high‐performance liquid chromatography. Biomedical Chromatography. 17(4). 268–275. 76 indexed citations
14.
Jetter, Alexander, Stephan Rietbrock, M. Sieber, et al.. (2002). Population pharmacokinetics of cyclo- phosphamide, doxorubicin and etoposide in 30 patients with BEACOPP chemotherapy. International Journal of Clinical Pharmacology and Therapeutics. 40(12). 586–588. 7 indexed citations
15.
Rietbrock, Stephan, et al.. (2000). Pharmacokinetics of inhaled anaesthetics in a clinical setting: description of a novel method based on routine monitoring data. British Journal of Anaesthesia. 84(4). 437–442. 15 indexed citations
16.
Rietbrock, Stephan, et al.. (2000). Inhibitory Effects of Silibinin on Cytochrome P‐450 Enzymes in Human Liver Microsomes. Pharmacology & Toxicology. 86(6). 250–256. 109 indexed citations
17.
Wissing, H., et al.. (2000). Pharmacokinetics of inhaled anaesthetics in a clinical setting: comparison of desflurane, isoflurane and sevoflurane. British Journal of Anaesthesia. 84(4). 443–449. 33 indexed citations
18.
Rietbrock, Stephan, et al.. (1999). Inhibitory Effects of Trospium Chloride on Cytochrome P450 Enzymes in Human Liver Microsomes. Pharmacology & Toxicology. 85(s2). 299–304. 28 indexed citations
19.
Harder, Sebastian, H. Baas, & Stephan Rietbrock. (1995). Concentration-Effect Relationship of Levodopa in Patients with Parkinson's Disease. Clinical Pharmacokinetics. 29(4). 243–256. 35 indexed citations
20.
Rietbrock, Stephan, Brigitte Keller‐Stanislawski, Petra Thürmann, & D. Brockmeier. (1992). Pharmacokinetic profile of a novel slow release preparation of molsidomine. European Journal of Clinical Pharmacology. 43(3). 273–276. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026